Q&A with Eric Dobson of Sheltowee Med Device Fund I, LP
Managing Partner
Principal Series:
Sheltowee Medical Device Fund has entered the $425B+ medical device industry with a team that has created over $3.5B in market cap in medical device companies in the last 12 years as founders, early employees, or investors. The diligence process is vastly more detailed and quantitative. And, the Leadership Team has cultivated a network of subject matter experts and acquirers that are part and parcel of the diligence process. We believe we have assembled an outstanding team that understands the challenges of early-stage investing, growth, commercialization, and liquidity in the medical device market. This is a staggeringly large market where fortunes can be made and still hold to a higher purpose of positively impacting millions of lives.
Join us for a private Family Office Insights webinar July 30th at 2:15 PM Eastern
Family Office Insights is a voluntary, “opt-in” collaborative peer-to-peer community of single family offices, qualified investors and institutional investors. Join the community here www.familyofficeinsights.com
Why is this effort different?
Three things distinguish this opportunity. First, every member of the Leadership Team and Scientific Advisory Board (SAB) have individually distinguished themselves and have come together to form a cohesive team of complementary experts with a passion for innovation and a drive for success. Second, the diligence process is unlike any other. It is vastly more detailed, more quantitative, and the team has cultivated a network of subject matter experts and acquirers unlike anything at this end of the venture market. Third, we have created a model that deemphasizes the founder by providing fractional leadership to these ventures allowing the founder to focus on what he/she does best, create a great product. This model has been proven over many years of development to reduce cost, expedite the time-to-market, and produce outstanding financial results.
Why should you attend and listen to this Q&A Session?
First, we believe this model will provide superior financial performance and impact millions of lives for the positive. Second, we believe this model is the future of early-stage venture capital investing. Third, we believe we have assembled an outstanding team that understands the challenges of early-stage investing, growth, commercialization, and liquidity in the medical device market. And, finally we stand ready to fully operationalize this venture with your help.
Why is this the right team?
Brian Doughty has distinguished his career in commercializing products with or acquire by Ethicon ($5B in revenue), Medtronic ($500M in revenue), Fox Hollow Technologies (exit to ev3 for $780M acquisition; $1.7B market cap), EKOS ($220M exit to Boston Scientific), Cardiovascular Systems (IPO; $1B market cap), SurPass Medical (exit to Stryker for $135M), and Apollo EndoSurgery (IPO). Eric Dobson has distinguished himself with exits for Facebook (6x for investors) and Arkis BioSciences (5x for investors). He led investments in two additional medical device companies both having strategic investment of $10M - $20M. Alex Day distinguished himself with fund leadership in the with two venture capital funds, Commonwealth Seed Capital Fund and the Owensboro Emerging Ventures Fund, and in founding Kentucky BioProcessing, LLC, which was acquired by RJ Reynolds. The SAB is well appointed with subject matter experts in cardiovascular processes, research and development, radiology, regulatory and compliance process, and commercialization of medical devices.
Eric Dobson of Sheltowee Med Device Fund I, LP
Eric Dobson is a seasoned entrepreneur and investor who has raised over $25 million in capital for multiple projects. He leads the Sheltowee Angel Network, which operates as a syndicate of angel groups in the Southeast and Midwest. Dr. Dobson has lead investments in 25 companies in the last eight years. Under Dr. Dobson’s leadership, SAN has enjoyed one 6x exit (Facebook IPO), one 5x exit (medical device acquisition by Integra Lifesciences), with one 3x exit pending. Dr. Dobson was instrumental in founding the Appalachian Investors Alliance, a syndicate of microventure funds across the Appalachian region focused on entrepreneurial readiness and access to capital under contract with the Appalachian Regional Commission. To date, 100+ AIA accredited investor members have incorporated eight angel/impact funds in as many Appalachian states which have placed $10 million in direct private investment into 27 entrepreneurial companies. This capital leveraged an additional $90 million in investments from outside the AIA region and network. Dr. Dobson received his Bachelor of Arts from the University of Tennessee, his Masters of Science from the University of South Carolina, and his Doctoral degree from the University of South Carolina.
Contact Eric: